tiprankstipranks
Amicus Therapeutics (FOLD)
NASDAQ:FOLD

Amicus (FOLD) Financial Statements

889 Followers

Amicus Financial Overview

Amicus's market cap is currently ―. The company's EPS TTM is $-0.517; its P/E ratio is -20.15; Amicus is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 115.08M$ 103.50M$ 94.50M$ 86.27M$ 88.10M
Gross Profit$ 103.76M$ 93.56M$ 85.39M$ 79.33M$ 78.71M
EBIT$ -6.50M$ 551.00K$ -16.24M$ -52.60M$ -60.96M
EBITDA$ -3.78M$ 3.50M$ -13.34M$ -50.68M$ -59.65M
Net Income Common Stockholders$ -33.84M$ -21.58M$ -43.23M$ 194.88M$ -55.87M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 286.20M$ 280.30M$ 265.63M$ 267.11M$ 293.60M
Total Assets$ 777.88M$ 764.08M$ 730.09M$ 700.52M$ 724.17M
Total Debt$ 445.06M$ 454.29M$ 452.17M$ 452.01M$ 452.12M
Net Debt$ 158.86M$ 173.99M$ 186.54M$ 184.90M$ 158.53M
Total Liabilities$ 617.71M$ 630.85M$ 618.51M$ 597.95M$ 601.12M
Stockholders Equity$ 160.17M$ 133.24M$ 111.58M$ 102.57M$ 123.05M
Cash Flow-
Free Cash Flow$ 1.73M$ -39.32M$ -18.67M$ -20.26M$ -80.04M
Operating Cash Flow$ 3.46M$ -37.76M$ -16.47M$ -18.32M$ -80.77M
Investing Cash Flow$ -23.96M$ 35.18M$ 50.34M$ 36.51M$ -66.70M
Financing Cash Flow$ 8.21M$ 37.62M$ 23.67M$ -7.83M$ 557.00K
Currency in USD

Amicus Earnings and Revenue History

Amicus Debt to Assets

Amicus Cash Flow

Amicus Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis